Suspension of trading
Quotes Eiger BioPharmaceuticals
Stocks
EIGR
US28249U2042
Biotechnology & Medical Research
|
Market Closed -
OTC Markets
19:27:07 27/09/2024 +04
|
5-day change | 1st Jan Change | ||
| 8.500 USD | -.--% |
|
-.--% | - |
| 01/10/24 | Eiger BioPharmaceuticals Files for Chapter 11 Bankruptcy as Liquidation Plan Takes Effect | CI |
| 30/09/24 | Eiger BioPharmaceuticals, Inc. Went Out of Business | CI |
Stock exchange
OTC Markets
EIGR 8.500 $
-.--%
13.53K
$
| Markets | Price | Change | Volumes |
|---|
Performance
| 3 years | -30.89% | ||
| 5 years | -96.26% | ||
| 10 years | -98.01% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
12,586,774
Net sales ()
16
Number of employees
25
Sales / Employee ()
1
Sales / Employee (USD)
1
Free-Float
86.47 %
Free-Float capitalization (USD)
10,883,196
Indicators
Moving average 5 days
8.5
Moving average 100 days
8.438
Price spread / (MMA5)
-.--%
Price spread / (MMA100)
-0.72%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -.--% | -30.89% | 12.59M | |
| -0.71% | -6.35% | -2.99% | +9.37% | 45.48B | |
| +0.21% | -2.98% | +337.74% | +520.30% | 43.68B | |
| +1.74% | -2.24% | +39.82% | +20.85% | 43.09B | |
| +1.38% | -3.28% | +6.84% | +73.19% | 39.4B | |
| -1.44% | -5.26% | +8.97% | +39.76% | 31.91B | |
| +0.87% | -2.60% | - | - | 17.31B | |
| +0.75% | -0.64% | +19.75% | +108.58% | 16.4B | |
| -0.31% | -2.78% | +10.78% | +30.20% | 14.24B | |
| +1.93% | -3.55% | +82.00% | +36.66% | 13.28B | |
| Average | +0.44% | -2.88% | +55.88% | +89.78% | 26.48B | |
| Weighted average by Cap. | +0.41% | -3.50% | +74.56% | +124.85% |
Historical Quotes: Eiger BioPharmaceuticals
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 3 years | 1.1 |  | 16 |
| 5 years | 1.1 | | 300.64 |
| 10 years | 1.1 | | 540 |
Monthly variations
Annual variations
| 2024 | +26.21% | ||
| 2023 | -80.97% | ||
| 2022 | -77.26% | ||
| 2021 | -57.77% | ||
| 2020 | -17.52% | ||
| 2019 | +46.65% | ||
| 2018 | -27.17% | ||
| 2017 | +19.74% | ||
| 2016 | -26.69% |
- Stock Market
- Stocks
- EIGR Stock
- Quotes Eiger BioPharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
